Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen To Present New Long-Term Repatha™ (Evolocumab) Data Analysis At ESC Congress 2015

[PR Newswire] – THOUSAND OAKS, Calif., Aug. 25, 2015 /PRNewswire/ — Amgen (AMGN) today announced that it will present six abstracts at the upcoming ESC Congress 2015, organized by the European Society of . . . → Read More: Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen To Present New Long-Term Repatha™ (Evolocumab) Data Analysis At ESC Congress 2015 Similar Articles: Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces 2015 Third Quarter Dividend Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Webcast Of 2015 First Quarter Financial Results Stock Update (NASDAQ:AMGN): U.S. FDA approves Amgen heart failure drug